# RESPIRICS INC: Form D filings

RESPIRICS INC, a pharmaceuticals company in Raleigh, NC, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on August 27, 2010, reports $146,257 sold of a $146,257 offering to 13 investors.

Find out what RESPIRICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RESPIRICS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RESPIRICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Frespirics-inc-1287016)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RESPIRICS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RESPIRICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Frespirics-inc-1287016)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6008 TRIANGLE DR STE 101, Raleigh, NC, 27617
- Phone: (919) 789-4220
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1287016

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 27, 2010 | New notice | $146,257 | $146,257 | $0 | 13 | Aug 27, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1287016/000128701610000002/0001287016-10-000002-index.htm) |
| May 4, 2010 | New notice | $4,639,200 | $3,726,283 | $912,917 | 50 | Apr 16, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1287016/000128701610000001/0001287016-10-000001-index.htm) |
| Sep 11, 2009 | New notice | $1,500,000 | $375,000 | $1,125,000 | 10 | Apr 16, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1287016/000128701609000003/0001287016-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| R. Brent Dixon | Director |  |
| James R. Butler | Director |  |
| Robert A. Casper | Director |  |
| John Q. Adams, Sr. | Director |  |
| Mark Celeste | Executive Officer, Director |  |
| Lary Snodgrass | Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Aug 23, 2010](https://specstream.ai/data/form-d/week/2010-08-23) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what RESPIRICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).